Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 26 | ECE2011 | Next issue

13th European Congress of Endocrinology

Poster Presentations

Endocrine tumours and neoplasia

Previous section
Endocrine disruptors
Table of contents
Next section
Female reproduction

ea0026p53 | Endocrine tumours and neoplasia

Insulinoma in crete: a rare tumor?

ea0026p54 | Endocrine tumours and neoplasia

Frequency, localisation of unusual metastases of medullary thyroid cancer and impact on survival: an observational study in 102 patients

ea0026p55 | Endocrine tumours and neoplasia

Diagnosis of post-surgical recurrence in patients with malignant insulinoma

ea0026p56 | Endocrine tumours and neoplasia

The T-box transcription factor TBX1, the candidate gene of 22q11.2 microdeletion/DiGeorge syndrome, is involved in human parathyroid tumorigenesis

ea0026p57 | Endocrine tumours and neoplasia

Clinicopathological characteristics of pancreatic neuroendocrine tumors at diagnosis

ea0026p58 | Endocrine tumours and neoplasia

A large adrenal tumour as a phenotypic manifestation of the Birt–Hogg–Dube syndrome

ea0026p59 | Endocrine tumours and neoplasia

Metabolic syndrome related to adrenal incidentaloma: observational study

ea0026p60 | Endocrine tumours and neoplasia

Development and characterisation of patient-individual tumor models for endocrine tumors

ea0026p61 | Endocrine tumours and neoplasia

Liposome based strategies for the treatment of adrenocortical carcinoma

ea0026p62 | Endocrine tumours and neoplasia

Injection systems for long-acting somatostatin analogs: a comparative assessment of preparation times and nurses' perceptions

ea0026p63 | Endocrine tumours and neoplasia

The influence of different ACTH assays on the ACTH concentrations of patients with small cell lung cancer

ea0026p64 | Endocrine tumours and neoplasia

Primary hyperparathyroidism in MEN1 patients: preferred surgical procedure and relation with genotype

ea0026p65 | Endocrine tumours and neoplasia

Significance of BRAF expression in nodular thyroid disease: prognostic and therapeutic implications

ea0026p66 | Endocrine tumours and neoplasia

Metabolic endocrine tumor activity is reflected by total 18F-DOPA PET tumor uptake in patients with a carcinoid tumor

ea0026p67 | Endocrine tumours and neoplasia

Ectopic mediastinal parathyroid adenoma: a case report

ea0026p68 | Endocrine tumours and neoplasia

Significant prognostic survival factors in patients with pancreatic neuroendocrine tumors

ea0026p69 | Endocrine tumours and neoplasia

Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH): is it linked to GH secretion?

ea0026p70 | Endocrine tumours and neoplasia

First prognostic analysis of stage III adrenocartical carcinoma patients after complete resection: a retrospective French Multicentric Study from the INCA-COMETE network

ea0026p71 | Endocrine tumours and neoplasia

Comparison of the efficacy and the tolerance of high-dose calcium and pentagastrin tests in patients with cured or persistent medullary thyroid cancer and in controls

ea0026p72 | Endocrine tumours and neoplasia

Distribution of mitotane and its two metabolites in liproprotein fractions of patients with adrenocortical carcinoma

ea0026p73 | Endocrine tumours and neoplasia

68Ga-DOTATATE PET shows a better diagnostic performance than octreoscan in patients with neuroendocrine tumors

ea0026p74 | Endocrine tumours and neoplasia

In vitro effect of the somatostatin analogue BIM 23704 on cell cycle timecourse in an ovarian carcinoma cell line

ea0026p75 | Endocrine tumours and neoplasia

T-type calcium channel blockers inhibit hormone secretion and induce apoptotic cell death in a medullary thyroid cancer cell line

ea0026p76 | Endocrine tumours and neoplasia

Management of type III neuroendocrine tumors of the stomach

ea0026p77 | Endocrine tumours and neoplasia

Could 99mTc labeled long-acting agonist of GLP-1 (Exendin-4) scintigraphy be a new tool in the diagnostics of unknown focus of insulinoma ? preliminary results

ea0026p78 | Endocrine tumours and neoplasia

A randomized, double-blind, placebo-controlled, multicenter phase III trial of everolimus + octreotide LAR versus placebo + octreotide LAR in patients with advanced neuroendocrine tumors (NET) (RADIANT-2): updated safety results

ea0026p79 | Endocrine tumours and neoplasia

A randomized, double-blind, placebo-controlled, multicenter phase III trial of everolimus in patients with advanced pancreatic neuroendocrine tumors (PNET) (RADIANT-3): updated safety results

ea0026p80 | Endocrine tumours and neoplasia

Mitotane reduces the chemoresistance phenotype in an adrenocortical carcinoma cell line

ea0026p81 | Endocrine tumours and neoplasia

Treatment of patients with metastatic well-differentiated gastroenteropancreatic tumors with RAD001(EVEROLIMUS)

ea0026p82 | Endocrine tumours and neoplasia

The role and extend of surgical resection in patients with gastric carcinoid tumours type 1

ea0026p83 | Endocrine tumours and neoplasia

Effectiveness of zolendronic acid yearly for preventing bone loss in patients with neuroendocrine tumors on somatostatin analogue therapy

ea0026p84 | Endocrine tumours and neoplasia

The demethylating agent 5-aza-2-deoxycytidine upregulates somatostatin type 2 receptor expression and enhances internalization of radiolabeled somatostatin analogue in human carcinoid tumour cells

ea0026p85 | Endocrine tumours and neoplasia

Comments on a series of patients affected by MEN1

ea0026p86 | Endocrine tumours and neoplasia

Role of peptide receptor radionuclide therapy (PRRT) in well and moderately differentiated neuroendocrine tumours

ea0026p87 | Endocrine tumours and neoplasia

Anatomical distribution of primary adrenal tumors: 10-year single center experience

ea0026p88 | Endocrine tumours and neoplasia

cAMP induces PATZ1 and estrogen receptor β nuclear re-localization in the human seminoma TCam-2 cell line

ea0026p89 | Endocrine tumours and neoplasia

The management of thyroid nodule in a patient with a non-thyroid primary cancer

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more